Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant

被引:0
作者
R Arlanov
T Lang
G Jedlitschky
E Schaeffeler
T Ishikawa
M Schwab
A T Nies
机构
[1] Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology,Department of Pharmacology
[2] Stuttgart and University of Tübingen,Department of Clinical Pharmacology
[3] Stuttgart,undefined
[4] Germany,undefined
[5] Center of Drug Absorption and Transport (C_DAT),undefined
[6] University Medicine of Greifswald,undefined
[7] RIKEN Center for Life Science Technologies,undefined
[8] Institute of Experimental and Clinical Pharmacology and Toxicology,undefined
[9] University Hospital of Tübingen,undefined
来源
The Pharmacogenomics Journal | 2016年 / 16卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Multidrug resistance protein 8 (ABCC11) is an efflux transporter for anionic lipophilic compounds, conferring resistance to antiviral and anticancer agents like 5-fluorouracil (5-FU). ABCC11 missense variants may contribute to variability in drug response but functional consequences, except for the ‘earwax variant’ c.538G>A, are unknown. Using the ‘Screen and Insert’ technology, we generated human embryonic kidney 293 cells stably expressing ABCC11 missense variants frequently occurring in different ethnic populations: c.57G>A, c.538G>A, c.950C>A, c.1637C>T, c.1942G>A, c.4032A>G. A series of in silico prediction analyses and in vitro plasma membrane vesicle uptake, immunoblotting and immunolocalization experiments were undertaken to investigate functional consequences. We identified c.1637C>T (T546M), previously associated with 5-FU-related toxicity, as a novel functionally damaging ABCC11 variant exhibiting markedly reduced transport function of 5-FdUMP, the active cytotoxic metabolite of 5-FU. Detailed analysis of 14 subpopulations revealed highest allele frequencies of c.1637C>T in Europeans and Americans (up to 11%) compared with Africans and Asians (up to 3%).
引用
收藏
页码:193 / 201
页数:8
相关论文
共 162 条
  • [1] Meyer UA(2013)Omics and Drug Response Annu Rev Pharmacol Toxicol 53 475-502
  • [2] Zanger UM(2011)Genomics and drug response N Engl J Med 364 1144-1153
  • [3] Schwab M(2010)Membrane transporters in drug development Nat Rev Drug Discov 9 215-236
  • [4] Wang L(2014)The role of transporters in toxicity and disease Drug Metab Dispos 42 541-545
  • [5] McLeod HL(2010)Drug transporter pharmacogenetics in nucleoside-based therapies Pharmacogenomics 11 809-841
  • [6] Weinshilboum RM(2011)Mammalian multidrug-resistance proteins (MRPs) Essays Biochem 50 179-207
  • [7] Giacomini KM(2003)MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine J Biol Chem 278 29509-29514
  • [8] Huang SM(2010)Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure Anticancer Agents Med Chem 10 617-624
  • [9] Tweedie DJ(2005)Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11) Mol Pharmacol 67 545-557
  • [10] Benet LZ(2006)Human multidrug resistance protein ABCC11 (MRP8), an apical efflux pump for steroid sulfates, is an axonal protein of the central and peripheral nervous system Neuroscience 137 1247-1257